Braun-Bostich & Associates’s Clorox CLX Stock Holding History

Braun-Bostich & Associates’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,901	Closed	-$315K	–	112
2021 Q3	$315K	Sell	1,901 -90	-5%	-$15.5K	0.59%	50
2021 Q2	$358K	Sell	1,991 -130	-6%	-$23.7K	0.65%	42
2021 Q1	$409K	Buy	2,121 +499	+31%	+$96.1K	0.79%	36
2020 Q4	$328K	Buy	+1,622	New	+$336K	0.66%	37
2019 Q3	–	Sell	-412	Closed	-$63K	–	125
2019 Q2	$63K	Hold	412	–	–	0.07%	175
2019 Q1	$66K	Hold	412	–	–	0.07%	184
2018 Q4	$64K	Hold	412	–	–	0.07%	161
2018 Q3	$62K	Hold	412	–	–	0.06%	168
2018 Q2	$56K	Hold	412	–	–	0.06%	170
2018 Q1	$55K	Sell	412 -777	-65%	-$104K	0.05%	168
2017 Q4	$177K	Buy	+1,189	New	+$162K	0.15%	114

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Braun-Bostich & Associates's CLX Position: Q4 2021 in Review

Braun-Bostich & Associates sold out of Clorox (CLX) in Q4 2021, closing a stake of 1,901 shares — an estimated $315K sold.

Braun-Bostich & Associates first reported a position in CLX in Q4 2017 and held it in 11 quarters. The position peaked at $409K in Q1 2021. 1,220 funds tracked by Wall St. Rank hold CLX as of Q4 2021.

Braun-Bostich & Associates reported no remaining Clorox position as of Q4 2021 after selling out during the quarter.
Braun-Bostich & Associates sold 1,901 Clorox shares in Q4 2021, an estimated $315K.
Braun-Bostich & Associates first reported a position in Clorox in Q4 2017 and held it in 11 quarters.
Braun-Bostich & Associates's Clorox position peaked at $409K in Q1 2021.
1,220 funds tracked by Wall St. Rank held Clorox as of Q4 2021.

Based on Braun-Bostich & Associates's 13F filing for Q4 2021, filed 11 Feb 2022.